95260 ⎘
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same
#3002FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS
#3003Substituted asymmetric ureas as modulators of ghrelin receptor activity
#3004Antiviral compounds
#3005Modulators of chemokine receptors
#3006Inhibitors of CXCR2
#3007Amide compound
#3008Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections
#3009Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#3010Tetrazole-substituted arylamides as PXand PXantagonists
#3011Synthesis and use of amine-containing flavonoids as potent anti-leishmanial agents
#3012Compound for organic electronic element, organic electronic element using same, and electronic device comprising same
#30136-amino-5,6,7,8-tetrahydronaphthalen-2-yl or 3-aminochroman-7-yl derivatives
#3014Compounds for the treatment of HIV
#3015Heterocyclic compound and organic light emitting element using same
#3016Cyclic amine azaheterocyclic carboxamides
#30176-acyl-1,2,4-triazine-3,5-dione derivative and herbicides
#3018Tetrahydronaphthalene estrogen receptor modulators and uses thereof
#3019Substituted 2-phenyl (AZA)benzofuran compounds for the treatment of hepatitis C
#3020Heteroaryl substituted heterocyclyl sulfones
#3021Nitrogen-containing heterocyclic compound
#3022Cyclopropylamines as LSD1 inhibitors
#3023Method of fluorination using iodonium ylides
#3024Anticancer agent
#3025HIV REPLICATION INHIBITING PYRIMIDINES
#3026COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
#3027Complexes
#3028Aryl- or heteroaryl-substituted benzene compounds
#3029Compound and organic light-emitting device including the same
#3030TrkA kinase inhibitors, compositions and methods thereof
#3031PRMT5 inhibitors and uses thereof
#3032Histone demethylase inhibitors
#3033N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof
#30342,5-DISUBSTITUTED CYCLOPENTANE CARBOXYLIC ACIDS FOR THE TREATMENT OF RESPIRATORY TRACT DISEASES
#3035Compounds and combinations for the treatment of HIV
#3036Benzoimidazol-1,2-yl amides as Kv7 channel activators
#3037C5AR ANTAGONISTS
#3038Cyclopropylamines as LSD1 inhibitors
#3039Dihydroxy aromatic heterocyclic compound
#3040Heteroaryl derivatives as CFTR modulators
#3041AMINOPYRAZOLONE DERIVATIVE
#3042MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#3043MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#3044Compounds useful as immunomodulators
#3045Therapeutically active compounds and their methods of use
#3046Indole derivatives for use in medicine
#3047Trail enhancers for the selective killing of cancer cells
#3048Alkylation of picolinamides with substituted chloroacylals utilizing a crown ether catalyst
#3049Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
#3050Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same
#3051DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#3052PYRIMIDINE HYDROXY AMIDE COMPOUNDS AS PROTEIN DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF
#3053Pyrazole compounds and their use as T-type calcium channel blockers
#3054Aromatic heterocyclic derivatives and pharmaceutical applications thereof
#3055COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE
#3056Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists
#3057Benzo-fused heterocyclic derivatives useful as agonists of GPR120
#3058DEUBIQUITINASE INHIBITORS
#3059Amine derivatives as potassium channel blockers
#3060Phenyl and benzodioxinyl substituted indazoles derivatives
#3061Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto
#30622,4-pyrimidinediamine compounds and their uses
#3063Antidiabetic tricyclic compounds
#3064Positive allosteric modulators of nicotinic acetylcholine receptor
#3065Compound and organic light-emitting device including same
#30661,3-benzodioxole derivative
#3067Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
#3068Human plasma kallikrein inhibitors
#3069Benzomorphan analogs and use thereof
#3070Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
#3071Pyridine and pyrazine derivative for the treatment of CF
#3072Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine
#3073Fumagillol heterocyclic compounds and methods of making and using same
#3074Mcl-1 antagonists
#30752-Amino-3,5,5-Trifluoro-3,4,5,6-Tetrahydropyridines as BACE1 Inhibitors for Treatment of Alzheimer's Disease
#3076N-(pyrid-4-yl)amides and N-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use
#3077Urea derivative or pharmacologically acceptable salt thereof
#3078NEW PHENYLAZETIDINECARBOXYLATE OR -CARBOXAMIDE COMPOUNDS
#3079Combinations for the treatment of neuroblastoma
#3080Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof
#3081Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
#3082Condensed-cyclic compound and organic light emitting device comprising the same
#3083Mitochondrial aldehyde dehydrogenase-2 binding compounds and methods of use thereof
#3084Carboxylic acid derivatives and use thereof in the preparation of prodrugs
#3085Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#3086Arginine methyltransferase inhibitors and uses thereof
#3087Process for the preparation of histamine H3 receptor modulators
#3088Compounds and methods for kinase modulation, and indications therefor
#3089Macrocyclic picolinamides as fungicides
#3090Heterocyclic compound
#3091Piperazine derivatives for treating disorders
#3092Diaminotriazine compounds as herbicides
#3093SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES
#3094COMPOUNDS AND THERAPEUTICAL USE THEREOF
#3095CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#3096Inhibitors of RPN11
#3097Sulfur derivatives as chemokine receptor modulators
#3098Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
#3099Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#3100Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers
#31012-amino-pyridine and 2-amino-pyrimidine derivatives and medicinal use thereof
#3102Disubstituted 1, 2, 4-triazine compound
#3103Janus kinase inhibitors and uses thereof
#3104NEW PESTICIDAL COMPOUNDS AND USES
#3105Amide derivatives and pharmaceutically acceptable salts thereof, preparation method thereof and medicinal application thereof
#3106Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
#3107Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor I
#3108COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT
#3109Pyridone amides as modulators of sodium channels
#3110Quinoxaline derivatives as GPR6 modulators
#3111AZA spiro alkane derivatives as inhibitors of metalloproteases
#3112Diazaspirocycloalkane and azaspirocycloalkane
#31131,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
#3114Kinase inhibitor
#3115Binding function (BF) site compounds as therapeutics and methods for their use
#3116PRMT5 inhibitors and uses thereof
#3117INSECTICIDAL COMPOUNDS
#3118Neprilysin inhibitors
#3119Aryl and heteroaryl ether compounds as ROR gamma modulators
#3120Benzamides
#3121Halogenated quinazolin-THF-amines as PDE1 inhibitors
#3122Quinolone-3-diarylethers
#3123Salts and prodrugs of 1-methyl-D-tryptophan
#3124Neprilysin inhibitors
#3125Amido-substituted azole compounds
#3126Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
#3127Substituted tricyclics and method of use
#3128SUBSTITUTED PYRAN DERIVATIVES
#3129Pyrimidone carboxamide compounds as PDE2 inhibitors
#3130PKM2 modulators and methods for their use
#3131Spliceostatin analogs and methods for their preparation
#3132Somatostatin receptor subtype 4 (SSTR4) agonists
#3133Compound and organic light-emitting device including the same
#3134Cysteine protease inhibitors and uses thereof
#3135Neprilysin inhibitors
#3136(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
#3137NOVEL HETEROBICYCLIC COMPOUNDS AS KAPPA OPIOID AGONISTS
#3138Pyrimidine FGFR4 inhibitors
#3139Therapeutics for the treatment of glaucoma
#3140Aminotriazole-based KDM1A inhibitors as epigenetic modulators
#3141Compounds useful in the synthesis of halichondrin B analogs
#3142Slow release of organoboronic acids in cross-coupling reactions
#31436 Phenyl or 6 Pyridin 3 YL Indazole Derivatives and Methods of Use
#3144Therapeutic compounds
#3145Kinase inhibitors
#3146Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
#3147Compound, organic optoelectronic element comprising same and display device thereof
#3148Tripeptide epoxy ketone protease inhibitors
#3149Compositions and methods for treating cancer
#3150Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors
#3151PRMT5 inhibitors and uses thereof
#3152Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
#3153Plant growth regulating compounds
#3154Therapeutic compounds
#31551,4-substituted piperidine derivatives
#3156Pharmaceutical compound
#3157Azetidine estrogen receptor modulators and uses thereof
#3158Fungicide N-cycloalkyl-N-bicyclicmethylene-carboxamide derivatives
#31595H-furan-2-one derivatives stabilization of organic material
#3160Cyclic peroxides as prodrugs for selective delivery of agents
#3161Bridged bicyclic kallikrein inhibitors
#3162Fused heterocyclic compounds as ion channel modulators
#3163Pyrimidine compounds containing seven-membered fused ring systems
#3164Amide compounds for treatment of complement mediated disorders
#3165Quinazolines as potassium ion channel inhibitors
#3166CHEMILUMINESCENT METHODS AND REAGENTS FOR ANALYTE DETECTION
#3167MCT4 inhibitors for treating disease
#3168Iodine(II)-mediated radiofluorination
#3169Pro-neurogenic compounds
#3170PRO-NEUROGENIC COMPOUNDS
#3171Nuclear receptor modulators
#3172COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#3173Compositions and methods for inhibiting cytochrome P450
#3174Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
#3175NOVEL 1-SUBSTITUTED INDAZOLE DERIVATIVE
#3176Triazoles for the treatment of Demyelinating Diseases
#3177Substituted phenazines as antimicrobial agents
#3178COMPOUND BINDING TO PPARG BUT NOT ACTING AS PROMOTER AND PHARMACEUTICAL COMPOSITION FOR TREATING PPARG-RELATED DISEASES CONTAINING SAME AS ACTIVE INGREDIENT
#3179Substituted pyridines and method of use
#3180Sulfonamide compounds and uses as TNAP inhibitors
#31813,3′-disubstituted indolines as inhibitors of cholesterol ester transfer protein
#3182Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
#3183Compounds for use as GPR120 agonists
#3184Inhibitors of histone deacetylase
#3185Bicyclic-fused heteroaryl or aryl compounds
#3186Heterocyclic estrogen receptor modulators and uses thereof
#3187Histone demethylase inhibitors
#3188Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides
#3189Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)
#3190Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating induced inflammatory bowel diseases such as crohn's disease
#3191Itraconazole analogues and methods of use thereof
#3192Substituted benzooxadiazole DNA-PK inhibitors
#3193Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
#3194Factor XIa inhibitors
#3195TETRACYCLIC COMPOUND
#3196Triazolone compounds as mPGES-1 inhibitors
#3197TOFA analogs useful in treating dermatological disorders or conditions
#3198Metallo-beta-lactamase inhibitors
#3199Benzimidazole and imadazopyridine carboximidamide compounds
#3200Pyrimidinyloxy benzene derivatives as herbicides
#3201Heterocyclic sulfonamide derivative and medicine comprising same
#3202Modulators of ATP-binding cassette transporters
#3203Hepatitis B antiviral agents
#3204Prodrugs of urolithins and uses thereof
#3205Histone demethylase inhibitors
#3206SUBSTITUTED BENZENE COMPOUNDS
#3207Bromodomain inhibitors
#3208Flouro-naphthyl derivatives
#3209Compounds and uses
#3210PYRROLIDINYL SULFONE DERIVATIVES AND THEIR USE AS ROR GAMMA MODULATORS
#3211Urea derivatives useful as kinase inhibitors
#3212Oxime-substituted amide compound and pest control agent
#3213Nrf2 regulators
#3214Nitrogen-containing six-membered cyclic derivatives and pharmaceutical composition comprising the same
#3215Quinazolin-THF-amines as PDE1 inhibitors
#3216PRODRUG COMPOUNDS
#3217TONABERSAT PRODRUGS
#3218Methods to treat lymphoplasmacytic lymphoma
#3219RORγ modulators
#32204-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors
#3221N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation
#3222Benzamides and nicotinamides as Syk modulators
#3223Compounds
#3224Compounds useful as modulators of TRPM8
#3225Composition comprising tetracyclic compound
#3226ANTI-ESTROGENIC COMPOUNDS
#3227NOVEL TRICYCLIC CALCIUM SENSING RECEPTOR ANTOGONISTS FOR THE TREATMENT OF OSTEOPOSOSIS
#3228Cyclic triazo and diazo sodium channel blockers
#3229N-arylmethyl sulfonamide negative modulators of NR2A
#3230Substituted indazole derivatives active as kinase inhibitiors
#3231Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
#3232Compounds as TNIK, IKKε and TBK1 inhibitors and pharmaceutical composition comprising same
#3233Substituted indazole derivatives active as kinase inhibitiors
#3234PSMA imaging agents
#3235Compounds, compositions and methods for inhibiting CNKSR1
#3236Methods of promoting wound healing using CRM1 inhibitors
#3237NOVEL COMPOUNDS AS JNK KINASE INHIBITORS
#32383-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#3239APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#3240Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors
#3241Chromene derivatives as phoshoinositide 3-kinases inhibitors
#3242Estrogen receptor beta agonists for use in treating mesothelioma
#3243INSECTICIDAL COMPOUNDS
#3244Substituted amino triazoles, and methods using same
#3245Viral replication inhibitors
#3246Inhibitors of lysine methyl transferase
#3247Inhibitors of lysine methyl transferase
#3248Dihydropyrazole GPR40 modulators
#3249Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
#3250Taxanes compounds, preparation method therefor, and uses thereof
#3251Quinazoline derivatives as TAM family kinase inhibitors
#3252Substituted quinazoline compounds and methods of use thereof
#3253N-substituted benzamides and methods of use thereof
#3254Bis-amide derivative and use thereof
#3255Aminoquinazoline and pyridopyrimidine derivatives
#3256Aziridinated triglycerides and polymers formed therefrom
#3257Coumarin based Hsp90 inhibitors with urea and ether substituents
#3258Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor 1
#3259TRPV1 Vanilloid Receptor Antagonists With A Bicyclic Portion
#3260Pyrazole derivatives as TNIK, IKKϵ and TBK1 inhibitor and pharmaceutical composition comprising same
#3261ORGANIC COMPOUNDS
#3262FLUOROMETHYL-SUBSTITUTED PYRROLE CARBOXAMIDES III
#3263Selective FKBP51 ligands for treatment of psychiatric disorders
#3264IDO inhibitors
#3265Activators of class I histone deacetlyases (HDACs) and uses thereof
#3266N-(monocyclic aryl),N'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
#3267Sulfated and unsulfated flavonoid oligomers as cancer therapeutics
#3268P2X4 receptor antagonist
#3269Cyclopropanecarboxamido-substituted aromatic compounds as anti-tumor agents
#3270Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain
#32716-aminoisoquinoline compounds
#3272Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
#3273N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors
#3274Treatment of diseases through administration of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
#3275Use of 15-benzylidence-14-deoxy-11, 12 -dehyroandrographolide derivative in manufacture of medicaments for protecting liver and anti-hepatitis C virus
#3276Pro-drugs of NSAIAs with very high skin and membranes penetration rates and their new medicinal uses
#3277HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
#3278Formation of macromolecules using iterative growth and related compounds
#32793-furyl-2-cyano-2-acrylamide derivative, preparation method therefor, pharmaceutical composition and use thereof
#3280Trail enhancers for the selective killing of cancer cells
#3281Inhibitors of beta-secretase
#3282Quinazolinone and isoquinolinone derivative
#3283N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
#3284DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE
#3285Compounds for cognitive enhancement and methods of use thereof
#3286Tau imaging probe
#3287Modulators of ATP-binding cassette transporters
#3288Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activities
#3289Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
#3290Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#3291S1P modulating agents
#3292Antibacterial agents: aryl myxopyronin derivatives
#3293FUNCTIONALIZED FURAN-2-SULFONAMIDES EXHIBITING ENDOTHELIAL LIPASE INHIBITION
#3294SHIP1 modulators and methods related thereto
#3295Synthesis of novel inhibitors of isoprenoid biosynthesis (ISPF)
#3296MONOARYLATION OF AROMATIC AMINES
#3297Inhibitors of human immunodeficiency virus replication
#3298Sweet flavor modifier
#3299Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors
#3300Inhibitors of histone deacetylase